Lupus

Browse news, expert commentary, and educational content on lupus.

Highlights

14-11-2022 | ACR 2022 | Conference coverage | News

Phase 3 trial supports add-on telitacicept for SLE

Addition of the recombinant fusion protein telitacicept to standard care may reduce disease activity and is well tolerated in people with systemic lupus erythematosus, research suggests.

01-11-2022 | Systemic lupus erythematosus | News

Dapagliflozin may warrant further investigation for SLE

Dapagliflozin deserves further study as an add-on therapy for reducing renal and cardiovascular risk in patients with systemic lupus erythematosus, suggest preliminary trial findings.

01-09-2022 | Cardiovascular disease | News

CV risk reduction should be ‘an integral part’ of autoimmune disease management

A large study published in The Lancet has found that people with autoimmune diseases have an approximately 1.4–3.6-fold increased risk for developing cardiovascular disease relative to the general population.

Keep up with podcasts on this topic, available on

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Image Credits

Close up of medical disposable syringe and vial/© Kuzmik_A / Getty Images / iStock, Close up young woman taking pill, holding water glass/© fizkes / stock.adobe.com, Clogged Artery, Arteriosclerosis Cholesterol plaque. 3d illustration/© Mohammed Haneefa Nizamudeen / Getty Images / iStock, Medicine Matters rheumatology/© Springer Healthcare, Apple Podcasts/© Apple Inc.; the Apple logo is a trademark of Apple Inc., registered in the U.S. and other countries, Google Podcasts/© Google; Google Podcasts and the Google Podcasts logo are trademarks of Google LLC, Spotify/© Spotify AB, TuneIn/© TuneIn, Inc.